As such, it can be said that adipokines play a crucial role in the relationship between obesity, psoriasis, and nonalcoholic fatty liver disease (NAFLD); adiponectin, a hormone that promotes insulin sensitivity and fatty acid oxidation, is closely associated with both psoriasis and NAFLD [113]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.